Wire flash
*ST Jiuding Under Investigation by CSRC for Inaccurate Accounting of Inventory and Investment Properties
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
On September 18, 2026, *ST Jiuding (600053.SH) announced in a filing that it received an 'Investigation Notice' from the China Securities Regulatory Commission (CSRC). The CSRC has opened an investigation into the company due to inaccurate accounting of its inventory and investment properties for the years 2023-2024, which is suspected of violating information disclosure regulations. The company stated that all of its business operations are currently proceeding normally and that it will actively cooperate with the investigation during the probe period. The announcement was reported by Cailian Press (cls), a Chinese financial media outlet.
Source report
Cailian Press, September 18 — *ST Jiuding (600053.SH) disclosed in a regulatory filing that it received an "Investigation Notice" from the China Securities Regulatory Commission (CSRC) on September 18, 2026.
The CSRC has decided to launch an investigation into the company due to inaccurate accounting of its inventory and investment properties for the years 2023 and 2024. The irregularities are suspected of violating information disclosure regulations.
According to the announcement:
- All of the company's business operations are currently proceeding normally.
- The company stated it will actively cooperate with the investigation during the probe period.
Source
财联社Eastern
Part of this Story
CSRC probes *ST Jiuding and Kangzhi Pharmaceutical for suspected information disclosure violations